Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists
申请人:Martin Fionna Mitchell
公开号:US20080261999A1
公开(公告)日:2008-10-23
Compounds of the formula I or a pharmaceutically acceptable salt thereof: processes for their preparation, pharmaceutical compositions which contain them and their uses in therapy.
公式I的化合物或其药学上可接受的盐:制备它们的过程,包含它们的制药组合物以及它们在治疗中的用途。
AZABICYCLOALKANE DERIVATIVES USEFUL AS NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
申请人:Eli Lilly & Company
公开号:EP1858857B1
公开(公告)日:2010-12-08
WO2023/61263
申请人:——
公开号:——
公开(公告)日:——
[EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS